North India’s Largest Hospital Chain Resubmits IPO Papers for ₹1,800 Cr, Aiming for 3,011 Beds by FY28

Gurugram-based Paras Healthcare has recently filed its Draft Red Herring Prospectus (DRHP) with SEBI as it seeks to capitalize on its second attempt to enter the public markets. The upcoming IPO is structured to include a fresh issue of ₹500 crore alongside an Offer for Sale (OFS) totaling ₹1,300 crore, culminating in a total issue size of ₹1,800 crore. The company’s prior attempt in July 2024 was rendered inactive after SEBI’s approval lapsed when the company failed to execute the offering within the approved timeframe. Key financial institutions, including JM Financial and BofA Securities India, are set to lead the issue, indicating significant interest from the financial sector.

Market sentiment surrounding the Paras Healthcare IPO appears cautiously optimistic as it re-enters the grey market. Although the specific grey market premium has not been disclosed, industry analysts suggest that heightened interest in healthcare sectors, especially post-pandemic, could drive favorable sentiment. The company’s operational trajectory has shown promising signs, with a notable turnaround from a loss in FY25 to a profit in FY26, which positions it as an attractive investment choice in the Indian IPO landscape, particularly given its focus on high-demand specialty medical care.

For Indian investors, the Paras Healthcare IPO presents a dual opportunity—investing in a healthcare provider poised for growth while also benefiting from the company’s strategic moves to strengthen its balance sheet. The deployment of IPO proceeds towards debt repayment and expansion initiatives underlines a commitment to bolstering operational efficiency and enhancing profitability. Furthermore, as the healthcare sector remains pivotal in India, amid ongoing reforms and greater demand for quality healthcare, the IPO is likely to garner significant attention, highlighting the increasing investor confidence in this crucial market segment.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)